Name | Value |
---|---|
Revenues | 70.6K |
Cost of Revenue | 22.8K |
Gross Profit | 47.8K |
Operating Expense | 1,668.6K |
Operating I/L | -1,620.9K |
Other Income/Expense | 39.9K |
Interest Income | 4.7K |
Pretax | -1,581.0K |
Income Tax Expense | 0.0K |
Net Income/Loss | -1,581.0K |
Nexalin Technology, Inc. is a medical device company specializing in neurostimulation products for mental health treatment. Its flagship product, the Nexalin Device, offers non-invasive and drug-free therapy for anxiety and insomnia by emitting a patented frequency-based waveform that stimulates positive responses in mid-brain structures. The company also focuses on developing Generation 2, a medical device undergoing clinical trials for addressing substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia.